Article Details

Third ADC with Synaffix's Technology Enters Clinical Development - PR Newswire

Retrieved on: 2021-09-29 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

Third ADC with Synaffix's Technology Enters Clinical Development - PR Newswire. View article details on hiswai:

Excerpt

Lepu Biopharma is an innovation-driven biopharmaceutical company focusing on oncology therapeutics. There are currently eight clinical stage drug candidates in ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up